Sal de Uvas Picot

Product NDC: 70565-580
11-digit product format: 705650580
Labeler code: 70565
Product ID: 70565-580_3e0b2017-5e0d-44a4-9431-afd15bcb7822
Type: HUMAN OTC DRUG
Nonproprietary name: Citric Acid monohydrate and Sodium bicarbonate
Dosage form: GRANULE, EFFERVESCENT
Route: ORAL
Labeler: Reckitt Benckiser Mexico, S.A. de C.V.
Application: part331
Marketing category: OTC MONOGRAPH FINAL
Marketing start: 2016-03-31
Marketing end: 0000-00-00
Substance: CITRIC ACID MONOHYDRATE; SODIUM BICARBONATE
Active strength: 2 g/1; g/1
NDC exclude flag: No
Listing certified through: 2020-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 5 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	70565-580		I	Inactivated by FDA	2026-10-05
excluded package	package	70565-580	70565-580-01	I	Inactivated by FDA	2026-10-05
excluded package	package	70565-580	70565-580-02	I	Inactivated by FDA	2026-10-05
excluded package	package	70565-580	70565-580-03	I	Inactivated by FDA	2026-10-05
excluded package	package	70565-580	70565-580-04	I	Inactivated by FDA	2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 45 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	70565-580-02	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	70565-580-01	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	70565-580-03	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	70565-580-04	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	70565-580-02	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	70565-580-01	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	70565-580-03	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	70565-580-04	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	70565-580-02	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	70565-580-01	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	70565-580-03	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	70565-580-04	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	70565-580-02	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	70565-580-01	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	70565-580-03	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	70565-580-04	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	70565-580-02	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	70565-580-01	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	70565-580-03	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	70565-580-04	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	70565-580-02	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	70565-580-01	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	70565-580-03	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	70565-580-04	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	70565-580-01	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	70565-580-02	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	70565-580-04	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	70565-580-03	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	70565-580-01	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	70565-580-02	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	70565-580-04	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	70565-580-03	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	70565-580-01	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	70565-580-02	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	70565-580-04	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	70565-580-03	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
95250459-30e4-45c1-b08a-993044f49109	Product name	2	20250805
726062af-1135-4707-a1d7-57256991bbf9	Product name	2	20250226
a21a21e5-f36d-4c1f-8918-def921b8f7e3	Product name	3	20250124
fb7ab793-2c12-4079-b100-a64f73bef25a	Product name	4	20240712
b0cbf770-6cc3-4aa4-9158-755110c2b9f7	Product name	2	20230717
dc7c5daa-021f-40dd-b00d-63982cb2067a	Product name	1	20230426
e2db08c6-133f-4f4f-afb4-e90a2418d6f6	Product name	1	20230320
6bd95106-a412-1dad-b9cc-4cb74bfb27ce	Product name	2	20230315
f1e0dc7e-7d61-4625-b6d9-4894927679d7	Product name	2	20211025
ce6d5c06-3ae0-18a6-d5b3-8cd3cc0f8906	Product name	7	20210625
9badc7be-250a-44ab-aa36-926af3f02679	Product name	1	20210527
f52be47f-7aa7-46c0-b1fa-50c18dd50206	Product name	1	20201029
08ffbcbf-26df-b99c-1dab-64fc4cfae89f	Product name	5	20200925
e4870509-7e28-6f92-f0be-dd3dd889a9cf	Product name	5	20200810
6e9d4a47-c464-b93e-aebc-ad7bffc9c4cd	Product name	2	20190619
444b3e50-f226-46ef-bfca-2e7035d140cd	Product name	1	20190611
816b97af-edc5-4060-aff1-b814bdbcad50	Product name	1	20190415
11ed6f83-cdd2-4637-8379-b1a1d3ae3cde	Product name	1	20181101
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
86c45a79-b9f0-4476-a27c-6e10db098497	Product name	1	20180125
419aab54-5d5a-4146-9453-026d4a9991be	Product name	2	20170525
26acd337-b838-40ac-bcbc-05c3b81c8712	Product name	1	20170323
08ffbcbf-26df-b99c-1dab-64fc4cfae89f	Product name	2	20160823
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831
290f523a-f9db-9774-b5a9-e1f908ac1782	Product name	1	20150828
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324
89dac932-b90a-4410-9ab1-84c53e57de25	Product name	1	20150316
19c71a3d-ed9c-166b-a7e5-38c250c35631	Product name	1	20140508
5668b646-cd56-c3c7-bdea-3f6b1a8840db	Product name	1	20140508
597b1cfd-7b31-5048-62be-ca5cd740da2f	Product name	1	20140508
684ea482-2e8b-14af-5664-b98f1e402036	Product name	1	20140508
810ab97e-f109-f41c-7c83-6a652a9cbf43	Product name	1	20140508
87711080-88eb-65c5-b2dd-bf99e700a372	Product name	1	20140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2dd	Product name	1	20140508
b060cc1a-fe47-856b-0b77-4448b5963de8	Product name	1	20140508
c6b65c52-69c7-df49-550a-a50c137f6218	Product name	1	20140508
ec2149b3-5c6d-5344-f757-c86411073075	Product name	1	20140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Related label table
NDC	Related label
70565-580-01	Sal de Uvas Picot ®
70565-580-02	Sal de Uvas Picot ®
70565-580-03	Sal de Uvas Picot ®
70565-580-04	Sal de Uvas Picot ®

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
70565-580-01	Sal de Uvas Picot	6 in 1 CARTON	GRANULE, EFFERVESCENT	6	3
70565-580-01	Sal de Uvas Picot	1 in 1 PACKET	GRANULE, EFFERVESCENT	1	3
70565-580-02	Sal de Uvas Picot	8 in 1 CARTON	GRANULE, EFFERVESCENT	8	3
70565-580-02	Sal de Uvas Picot	1 in 1 PACKET	GRANULE, EFFERVESCENT	1	3
70565-580-03	Sal de Uvas Picot	1 in 1 PACKET	GRANULE, EFFERVESCENT	1	3
70565-580-03	Sal de Uvas Picot	12 in 1 CARTON	GRANULE, EFFERVESCENT	12	3
70565-580-04	Sal de Uvas Picot	50 in 1 CARTON	GRANULE, EFFERVESCENT	50	3
70565-580-04	Sal de Uvas Picot	1 in 1 PACKET	GRANULE, EFFERVESCENT	1	3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
70565-580	SAL DE UVAS PICOT (CITRIC ACID MONOHYDRATE AND SODIUM BICARBONATE) GRANULE, EFFERVESCENT [RECKITT BENCKISER MEXICO, S.A. DE C.V.]	3	Legacy NDC, 8 package rows	20161213_2d4e9346-7011-4595-afd1-bae9d8651ea2.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
2968PHW8QP	CITRIC ACID MONOHYDRATE	5949-29-1	CITRIC ACID MONOHYDRATE
8MDF5V39QO	SODIUM BICARBONATE	144-55-8	SODIUM BICARBONATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1795948	citric acid 1.949 GM / sodium bicarbonate 2.485 GM Powder for Oral Solution	PSN	ff6ac79d-564d-4abf-83c7-b01751249c7f	4
1795950	picot 1.949 GM / 2.485 GM Powder for Oral Solution	PSN	ff6ac79d-564d-4abf-83c7-b01751249c7f	4
1795950	citric acid 1949 MG / sodium bicarbonate 2485 MG Powder for Oral Solution [Picot]	SBD	ff6ac79d-564d-4abf-83c7-b01751249c7f	4
1795948	citric acid 1949 MG / sodium bicarbonate 2485 MG Powder for Oral Solution	SCD	ff6ac79d-564d-4abf-83c7-b01751249c7f	4
1795948	citric acid 1.949 GM / sodium bicarbonate 2.485 GM Powder for Oral Solution	SY	ff6ac79d-564d-4abf-83c7-b01751249c7f	4
1795948	Citric Acid 1949 MG / NaHCO3 2485 MG Powder for Oral Solution	SY	ff6ac79d-564d-4abf-83c7-b01751249c7f	4
1795950	Citric Acid 1949 MG / NaHCO3 2485 MG Powder for Oral Solution [Picot]	SY	ff6ac79d-564d-4abf-83c7-b01751249c7f	4
1795950	Picot 1.949 GM / 2.485 GM Powder for Oral Solution	SY	ff6ac79d-564d-4abf-83c7-b01751249c7f	4
1795950	sal de uvas picot 1.949 GM / 2.485 GM Powder for Oral Solution	SY	ff6ac79d-564d-4abf-83c7-b01751249c7f	4
1795948	citric acid 1.949 GM / sodium bicarbonate 2.485 GM Powder for Oral Solution	PSN	2d4e9346-7011-4595-afd1-bae9d8651ea2	3
1795950	picot 1.949 GM / 2.485 GM Powder for Oral Solution	PSN	2d4e9346-7011-4595-afd1-bae9d8651ea2	3
1795950	citric acid 1949 MG / sodium bicarbonate 2485 MG Powder for Oral Solution [Picot]	SBD	2d4e9346-7011-4595-afd1-bae9d8651ea2	3
1795948	citric acid 1949 MG / sodium bicarbonate 2485 MG Powder for Oral Solution	SCD	2d4e9346-7011-4595-afd1-bae9d8651ea2	3
1795948	citric acid 1.949 GM / sodium bicarbonate 2.485 GM Powder for Oral Solution	SY	2d4e9346-7011-4595-afd1-bae9d8651ea2	3
1795948	Citric Acid 1949 MG / NaHCO3 2485 MG Powder for Oral Solution	SY	2d4e9346-7011-4595-afd1-bae9d8651ea2	3
1795950	Citric Acid 1949 MG / NaHCO3 2485 MG Powder for Oral Solution [Picot]	SY	2d4e9346-7011-4595-afd1-bae9d8651ea2	3
1795950	Picot 1.949 GM / 2.485 GM Powder for Oral Solution	SY	2d4e9346-7011-4595-afd1-bae9d8651ea2	3
1795950	sal de uvas picot 1.949 GM / 2.485 GM Powder for Oral Solution	SY	2d4e9346-7011-4595-afd1-bae9d8651ea2	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
70565-580-01	70565058001	6 PACKET in 1 CARTON (70565-580-01) > 1 GRANULE, EFFERVESCENT in 1 PACKET	6 packet	2016-03-31	0000-00-00	No	No	Current
70565-580-02	70565058002	8 PACKET in 1 CARTON (70565-580-02) > 1 GRANULE, EFFERVESCENT in 1 PACKET	8 packet	2016-03-31	0000-00-00	No	No	Current
70565-580-03	70565058003	12 PACKET in 1 CARTON (70565-580-03) > 1 GRANULE, EFFERVESCENT in 1 PACKET	12 packet	2016-03-31	0000-00-00	No	No	Current
70565-580-04	70565058004	50 PACKET in 1 CARTON (70565-580-04) > 1 GRANULE, EFFERVESCENT in 1 PACKET	50 packet	2016-03-31	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Sal De Uvas Picot	Navajo Manufacturing Company Inc.	2024-10-02	HUMAN OTC DRUG LABEL	4
Sal de Uvas Picot ®	Reckitt Benckiser Mexico, S.A. de C.V.	2016-12-10	HUMAN OTC DRUG LABEL	3